Position in MRK
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$5,449,813
+$412,790 QoQ
Shares Held
42,411
+1.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#1,007
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Roundview Capital LLC holds $44,317,424 across 9 Drug Manufacturers - General names. MRK ranks #4 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
72,050 | $18,298,538 | |
| 2 | LLY |
ELI LILLY & Co
|
8,070 | $9,679,400 | |
| 3 | ABBV |
AbbVie Inc.
|
30,467 | $7,666,715 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
42,411 | $5,449,813 | |
| 5 | NVO |
Novo Nordisk A S
|
32,028 | $1,535,422 | |
| 6 | PFE |
Pfizer Inc
|
23,438 | $564,387 | |
| 7 | NVS |
Novartis AG
|
2,707 | $424,241 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,618 | $381,329 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,449,813 | 42,411 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $5,037,023 | 41,874 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $4,352,395 | 41,349 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $3,478,310 | 41,443 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,295,668 | 41,633 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $3,967,571 | 44,202 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $4,576,577 | 46,005 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $5,195,483 | 45,751 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,654,317 | 45,673 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $6,020,086 | 45,624 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $4,884,968 | 44,808 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $4,527,843 | 43,981 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,363,527 | 55,148 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $5,822,511 | 54,728 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $5,991,300 | 54,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,580,378 | 53,186 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $4,809,673 | 52,755 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,310,989 | 52,541 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $4,031,340 | 52,601 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,820,545 | 50,866 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $4,035,174 | 51,886 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $4,059,947 | 52,665 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $4,187,176 | 51,188 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $4,232,940 | 51,030 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $4,044,670 | 52,304 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,935,633 | 51,152 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||